Discovery and development of engineered modular protein formats being drug discovery services; Discovery and development of new drug candidate material, namely, drug discovery services; Research and development of therapeutic antibodies and pharmaceuticals, and research and development of technology in the field of therapeutic antibodies and pharmaceuticals; Drug Discovery services, and research, and development services in the field of pharmaceutical preparations and substances; Drug Discovery services, and research, and development of therapeutic antibodies and pharmaceuticals; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Pharmaceutical, therapeutic, and diagnostic drug discovery services; Medical research in the field nature of engineered modular protein formats

'antibodi':30,44,72 'candid':19 'clinic':87 'develop':3,15,27,36,53,69 'diagnost':92 'discoveri':1,11,13,23,48,64,94 'drug':10,18,22,47,63,93 'engin':5,103 'field':41,57,83,100 'format':8,106 'inform':80 'materi':20 'medic':76,96 'modular':6,104 'name':21 'natur':101 'new':17 'pharmaceut':32,46,59,74,85,89 'prepar':60 'protein':7,105 'provid':75 'research':25,34,51,67,79,97 'scientif':78 'servic':12,24,49,54,65,95 'substanc':62 'technolog':38 'therapeut':29,43,71,90 'trial':88

CONTRA-MAB

Owner

Goods & Services